» Articles » PMID: 32054068

Antimicrobial Activity of Host-Derived Lipids

Overview
Specialty Pharmacology
Date 2020 Feb 15
PMID 32054068
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Host-derived lipids are increasingly recognized as antimicrobial molecules that function in innate immune activities along with antimicrobial peptides. Sphingoid bases and fatty acids found on the skin, in saliva and other body fluids, and on all mucosal surfaces, including oral mucosa, exhibit antimicrobial activity against a variety of Gram positive and Gram negative bacteria, viruses, and fungi, and reduce inflammation in animal models. Multiple studies demonstrate that the antimicrobial activity of lipids is both specific and selective. There are indications that the site of action of antimicrobial fatty acids is the bacterial membrane, while the long-chain bases may inhibit cell wall synthesis as well as interacting with bacterial membranes. Research in this area, although still sporadic, has slowly increased in the last few decades; however, we still have much to learn about antimicrobial lipid mechanisms of activity and their potential use in novel drugs or topical treatments. One important potential benefit for the use of innate antimicrobial lipids (AMLs) as antimicrobial agents is the decreased likelihood side effects with treatment. Multiple studies report that endogenous AML treatments do not induce damage to cells or tissues, often decrease inflammation, and are active against biofilms. The present review summarizes the history of antimicrobial lipids from the skin surface, including both fatty acids and sphingoid bases, in multiple human body systems and summarizes their relative activity against various microorganisms. The range of antibacterial activities of lipids present at the skin surface and in saliva is presented. Some observations relevant to mechanisms of actions are discussed, but are largely still unknown. Multiple recent studies examine the therapeutic and prophylactic uses of AMLs. Although these lipids have been repeatedly demonstrated to act as innate effector molecules, they are not yet widely accepted as such. These compiled data further support fatty acid and sphingoid base inclusion as innate effector molecules.

Citing Articles

Chemical Composition, Free Radicals and Pathogenic Microbes in the Extract Derived from : In Silico and In Vitro Approaches.

Oumassi F, Chebbac K, Ben Ali N, Kaabi S, El Ansari Z, Metouekel A Mar Drugs. 2024; 22(12).

PMID: 39728138 PMC: 11677173. DOI: 10.3390/md22120565.


Exploring the landscape of Lipid Nanoparticles (LNPs): A comprehensive review of LNPs types and biological sources of lipids.

Alfutaimani A, Alharbi N, Alahmari A, Alqabbani A, Aldayel A Int J Pharm X. 2024; 8:100305.

PMID: 39669003 PMC: 11635012. DOI: 10.1016/j.ijpx.2024.100305.


Synthesis of cationic -acylated thiazolidine for selective activity against Gram-positive bacteria and evaluation of -acylation's role in membrane-disrupting activity.

Pious A, Venkatasubramanian V, Singaravelu D, Ramesh S, Ameen F, Veerappan A RSC Med Chem. 2024; .

PMID: 39507614 PMC: 11537284. DOI: 10.1039/d4md00626g.


The epidermal lipid-microbiome loop and immunity: Important players in atopic dermatitis.

Wu J, Li L, Zhang T, Lu J, Tai Z, Zhu Q J Adv Res. 2024; 68:359-374.

PMID: 38460775 PMC: 11785582. DOI: 10.1016/j.jare.2024.03.001.


Metabolomic signatures of intestinal colonization resistance against in mice.

Shayya N, Bandick R, Busmann L, Mousavi S, Bereswill S, Heimesaat M Front Microbiol. 2024; 14:1331114.

PMID: 38164399 PMC: 10757985. DOI: 10.3389/fmicb.2023.1331114.


References
1.
Klein E, Smith D, Laxminarayan R . Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis. 2008; 13(12):1840-6. PMC: 2876761. DOI: 10.3201/eid1312.070629. View

2.
Do T, Moshkani S, Castillo P, Anunta S, Pogosyan A, Cheung A . Lipids including cholesteryl linoleate and cholesteryl arachidonate contribute to the inherent antibacterial activity of human nasal fluid. J Immunol. 2008; 181(6):4177-87. PMC: 2597438. DOI: 10.4049/jimmunol.181.6.4177. View

3.
Bibel D, Aly R, Shinefield H . Inhibition of microbial adherence by sphinganine. Can J Microbiol. 1992; 38(9):983-5. DOI: 10.1139/m92-158. View

4.
Isaacs C, Kashyap S, Heird W, Thormar H . Antiviral and antibacterial lipids in human milk and infant formula feeds. Arch Dis Child. 1990; 65(8):861-4. PMC: 1792470. DOI: 10.1136/adc.65.8.861. View

5.
Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A . Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin?. J Invest Dermatol. 1991; 96(4):523-6. DOI: 10.1111/1523-1747.ep12470233. View